Neena Kanwar

President & CEO at NUCM Associates Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Halton Hills, Ontario, Canada, CA
Languages
  • English -
  • Hindi -
  • Punjabi -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Nuclear Medicine Technologist
    The Michener Institute for Applied Health Sciences

Experience

    • Canada
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • President & CEO
      • Jan 2020 - Present

      NUCM Associates Inc. is a Health Canada Licensed, GMP Production Laboratory situated in Oakville, Ontario. NUCM possesses a Drug establishment License (DEL), along with a CNSC Processing License for Radioisotopes. These licenses permit NUCM to operate as a centralized radiopharmacy provider (CRP) in Canada. NUCM is proud to be a trusted partner to Nuclear Medicine partners in Ontario. As a company, NUCM understands its responsibility in providing safe, efficacious, and high-quality radiopharmaceutical products (RP’s) to Nuclear Medicine departments (hospitals and independent healthcare facilities-IHF’s), in Ontario. Show less

    • Past President & CEO
      • Jan 1988 - Mar 2018

      PAST PRESIDENT + FOUNDER (12 direct + 400 indirect staff | $2M CapEx | $60M OpEx | $70M P&L) Navigated through skepticism, negativity, adversity and changing culture as the company rapidly expanded, building collaboration, encouraging open dialogue, maintaining morale and championing the team to excel. Planned and influenced massive expansion steering the business into recognition as a market leader and the largest provider of nuclear cardiology in North America. Oversaw and developed proprietary IT technology, now entering the third generation, to allow remote management of all sites from one central location. Sourced acquisition opportunities across North America and conducted due diligence, negotiating and signing acquisition agreements with 11 new sites. Catapulted revenue from $29M in 2010 to $76M in 2014, advancing EBITDA growth from $4M in 2010 to $10M in 2014 despite the challenge of government fee cuts. Acknowledged within the industry as an innovative leading-edge enterprise providing greater specificity and sensitivity, enhancing prognostic information while remaining robust and scalable for future growth. Created and launched client-focused services including a measurement program to monitor client satisfaction, providing senior management with the ability to address negative issues and optimize superior patient and physician services. Consistently clocked a >95% client satisfaction score for patients and physicians based on satisfaction surveys conducted daily, outperforming the standard industry satisfaction rate of 70% to 75%. Crafted and implemented an innovative, enticing marketing strategy focused on primary care physicians, differentiating from the competition's focus on specialists. Defined and organize physician and patient educational events, ensure attendance at medical conferences and patient awareness events, and host educational seminars aimed at the referring community knowledgeable in the latest test ordering practices. Show less

    • Canada
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Nuclear Medicine Technologist
      • Sep 1982 - Jan 1988

Education

  • The Michener Institute
    Registered Technologist, Nuclear Medical Technology/Technologist
    1979 - 1981
  • University of Toronto
    Bachelor of Science (B.Sc.), Biology, General
    1976 - 1979

Community

You need to have a working account to view this content. Click here to join now